This course will be published in February 2026. Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new […]
This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities, with a comparative analysis […]
This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT, SPECT/CT, and PET/MRI systems, learning how hybrid imaging […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
This intensive 1,5-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More info will come soon Learning Objectives Target Audience Faculty Event Overview
This 1,5-day course focuses on the growing field of integrated imaging in infectious and inflammatory diseases in children, with an emphasis on hybrid imaging. The panelists will introduce the participants […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More information will come soon. Learning Objectives More info will come soon. Target Audience More info will come soon. Faculty Registration Details
More info will come soon Learning Objectives Target Audience Faculty Event Overview
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
